Translate
Moderna Inc
About
Moderna Inc (NASDAQ:MRNA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
Apr 15 2026
Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
Apr 6 2026
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
Mar 3 2026
Moderna Resolves Global Patent Litigation with Arbutus/Genevant
Feb 27 2026
European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
Recent Videos
Bayer’s Monsanto is suing Pfizer, BioNTech, Moderna, over alleged patent infringements 🧬 💉
Apr 22, 2026
#MODERNA, #모더나 유럽에서 콤보 #독감, #코로나 #백신 허가받아...COMBRIAX, 한번 #주사로 #인플루엔자와 코로나19 동시 예방
Apr 22, 2026
NVAX Update: New Data vs Moderna (This Actually Matters)
Apr 20, 2026
Everyone saw Cicada. Nobody saw the trade.
Apr 19, 2026
Financials
Revenue
$1.94 B
Market Cap
$19.51 B
EPS
-7.26